Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07122245

Demographics of Lung Cancer in Females

Demographics of Lung Cancer in Female Patients: A Retrospective Based Analysis

Status
Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Mansoura University Hospital · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

Lung cancer has been the most common and fatal type of cancer; indeed worldwide incidence of lung cancer is alarming. It is considered a leading cause of cancer- related deaths among males and females due to environmental pollution, occupational exposure, genetic susceptibility, increasing number of smokers and others.

Detailed description

Lung cancer has been the most common and fatal type of cancer; indeed worldwide incidence of lung cancer is alarming. It is considered a leading cause of cancer- related deaths among males and females due to environmental pollution, occupational exposure, genetic susceptibility, increasing number of smokers and others. Moreover, a large proportion of people living in low and middle income countries are exposed to secondhand smoke (SHS) in their homes, workplaces, and other public places. Although, lung cancer had become one of fatality causes of the 20th century due to an increasing life span combined with exposures to various etiologic factors, it is one of the leading causes of preventable deaths. There are various important risk factors other than tobacco smoking that can contribute substantially to the lung cancer mortality in never smokers; these other lung carcinogens often act in an additive or synergistic manner in individuals who smoke tobacco products.

Conditions

Interventions

TypeNameDescription
BEHAVIORALDemographics and risk factors of lung cancerA retrospective cohort study will be conducted on bronchogenic carcinoma patients who had been presented to and diagnosed at chest diseases department, Oncology Center Mansoura University (OCMU).

Timeline

Start date
2025-08-07
Primary completion
2026-02-07
Completion
2026-04-07
First posted
2025-08-14
Last updated
2025-08-14

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07122245. Inclusion in this directory is not an endorsement.